Clinical Trial Update: Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of N-acetylcysteine on pulmonary function in high-risk patients undergoing off-pump coronary artery bypass surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Occlusion | Phase 4 | Status: COMPLETED